Neurological imaging of brain damages after radiotherapy and/or chimiotherapy

Journal of Neuroradiology

Volumn 41, Issue 1, 2014, Pages 52-70

  Martino, A ^a   Krainik, A ^a   Pasteris, C ^a   Hoffmann, D ^a   Chabardes, S ^a   Berger, F ^b   Le Bas, J F ^a   Cantin, S ^a   Attye, A ^a   Grand, S ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

Brain tumor; Chemotherapy; Radiotherapy; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BEVACIZUMAB; BLEOMYCIN; BORTEZOMIB; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; IRINOTECAN; METHOTREXATE; PACLITAXEL; RITUXIMAB; SORAFENIB; SUNITINIB; TEMOZOLOMIDE;

ANOREXIA; ARTERIAL THROMBOEMBOLISM; ARTERY DISEASE; ARTICLE; ATHEROSCLEROTIC PLAQUE; ATTENTION DISTURBANCE; BEHAVIOR DISORDER; BLOOD CLOTTING DISORDER; BRAIN CALCIFICATION; BRAIN DAMAGE; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN VASCULITIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CAPILLARY LEAK SYNDROME; CAROTID ARTERY INJURY; CAROTID ARTERY OBSTRUCTION; CAROTID ARTERY THROMBOSIS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; CONVULSION; DEMENTIA; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; ENCEPHALITIS; ENDOTHELIAL DYSFUNCTION; FEVER; GERM CELL TUMOR; GLIOBLASTOMA; HEADACHE; HEMATOMA; HUMAN; HYPERTENSION; INTRACRANIAL HYPERTENSION; LEUKEMIA; LEUKOENCEPHALOPATHY; MEMORY DISORDER; NAUSEA; NAUSEA AND VOMITING; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROTOXICITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PAPILLEDEMA; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PSEUDOPROGRESSION; PSEUDORESPONSE; RADIATION INDUCED EMESIS; RADIATION INDUCED NEOPLASM; RADIATION NECROSIS; SOMNOLENCE; TELANGIECTASIA; THROMBOCYTE DISORDER; THROMBOPHLEBITIS; TUMOR GROWTH; VEIN THROMBOSIS; VISUAL DISORDER; BRAIN DISEASES; CHEMORADIOTHERAPY; PROCEDURES; RADIATION INJURIES; TREATMENT OUTCOME;

BRAIN DISEASES; CHEMORADIOTHERAPY; HUMANS; NEUROIMAGING; RADIATION INJURIES; TREATMENT OUTCOME;

EID: 84897658557     PISSN: 01509861     EISSN: 17730406     Source Type: Journal    
DOI: 10.1016/j.neurad.2013.07.005     Document Type: Article

References (84)

1. Delattre J.Y., Shapiro W.R., Posner J.B. Acute effects of low-dose cranial irradiation on regional capillary permeability in experimental brain tumors. J Neurol Sci 1989, 90:147-153.
2. Bartynski W.S. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008, 29:1043-1049.
3. Wick A., Felsberg J., Steinbach J.P., et al. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma. J Clin Oncol 2007, 25:3357-3361.
4. Wong C.S., Van der Kogel A.J. Mechanisms of radiation injury to the central nervous system: implications for neuroprotection. Mol Interv 2004, 4:273-284.
5. Zakarija A., Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005, 31:681-690.
6. Benziada-Boudour A., Schmitt E., Kremer S., et al. Posterior reversible encephalopathy syndrome: a case of unusual diffusion-weighted MR images. J Neuroradiol 2009, 36:102-105.
7. Ricard D., Soussain C., Psimaras D. Neurotoxicity of the CNS: diagnosis, treatment, and prevention. Rev Neurol (Paris) 2011, 167:737-745.
8. Hunault-Berger M., Chevallier P., Delain M., et al. Changes in anti-thrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study. Haematologica 2008, 93:1488-1494.
9. Erbetta A., Salmaggi A., Sghirlanzoni A., et al. Clinical and radiological features of brain neurotoxicity caused by antitumor and immunosuppressant treatments. Neurol Sci 2008, 29:131-137.
10. Papet C., Gutzeit A., Pless M. Two cases of cerebral sinus venous thrombosis following chemotherapy for non-seminomatous germ cell tumor. Case Rep Oncol 2011, 4:555-559.
11. El Amrani M., Aidi S., Amarenco P. Cerebral ischemic events and anti-cancer therapy. Rev Neurol (Paris) 2003, 159:371-380.
12. Rollins N., Winick N., Bash R., et al. Acute methotrexate neurotoxicity: findings on diffusion-weighted imaging and correlation with clinical outcome. AJNR Am J Neuroradiol 2004, 25:1688-1695.
13. Kastenbauer S., Wiesmann M., Pfister H.W. Cerebral vasculopathy and multiple infarctions in a woman with carcinomatous meningitis while on treatment with intrathecal methotrexate. J Neurooncol 2000, 48:41-45.
14. Fraum T.J., Kreisl T.N., Sul J., et al. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J Neurooncol 2011, 105:281-289.
15. Delattre J.Y., Poisson M. Neurologic complications of brain radiotherapy: contribution of experimental studies. Bull Cancer 1990, 77:715-724.
16. Li Y.Q., Jay V., Wong C.S. Oligodendrocytes in the adult rat spinal cord undergo radiation-induced apoptosis. Cancer Res 1996, 56:5417-5422.
17. Atkinson S.L., Li Y.Q., Wong C.S. Apoptosis and proliferation of oligodendrocyte progenitor cells in the irradiated rodent spinal cord. Int J Radiat Oncol Biol Phys 2005, 62:535-544.
18. Ricard D., De Greslan T., Soussain C., et al. Neurological damage of brain tumor therapy. Rev Neurol (Paris) 2008, 164:575-587.
19. Armstrong C., Ruffer J., Corn B., et al. Biphasic patterns of memory deficits following moderate-dose partial-brain irradiation: neuropsychologic outcome and proposed mechanisms. J Clin Oncol 1995, 13:2263-2271.
20. Sichez N., Chatellier G., Poisson M., et al. Supratentorial gliomas: neuropsychological study of long-term survivors. Rev Neurol (Paris) 1996, 152:261-266.
21. Vigliani M.C., Sichez N., Poisson M., et al. A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 1996, 35:527-533.
22. Klein M., Heimans J.J., Aaronson N.K., et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002, 360:1361-1368.
23. Hygino da Cruz L.C., Rodriguez I., Domingues R.C., et al. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of post treatment glioma. AJNR Am J Neuroradiol 2011, 32:1978-1985.
24. Taal W., Brandsma D., de Bruin H.G., et al. Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemo irradiation with temozolomide. Cancer 2008, 113:405-410.
25. Fink J.R., Carr R.B., Matsusue E., et al. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from post treatment effects. J Magn Reson Imaging 2012, 35:56-63.
26. Sundgren P.C. MR spectroscopy in radiation injury. AJNR Am J Neuroradiol 2009, 30:1469-1476.
27. Zeng Q.S., Li C.F., Zhang K., et al. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007, 84:63-69.
28. de Wit M.C.Y., de Bruin H.G., Eijkenboom W., et al. Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression. Neurology 2004, 63:535-537.
29. Brandsma D., Stalpers L., Taal W., et al. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol 2008, 9:453-461.
30. Brandes A.A., Franceschi E., Tosoni A., et al. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 2008, 26:2192-2197.
31. Macdonald D.R., Cascino T.L., Schold S.C., et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990, 8:1277-1280.
32. van den Bent M.J., Vogelbaum M.A., Wen P.Y., et al. End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria. J Clin Oncol 2009, 27:2905-2908.
33. Payer F. Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme. Wien Med Wochenschr 2011, 161:13-19.
34. Wen P.Y., Macdonald D.R., Reardon D.A., et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 2010, 28:1963-1972.
35. Sawlani R.N., Raizer J., Horowitz S.W., et al. Glioblastoma: a method for predicting response to antiangiogenic chemotherapy by using MR perfusion imaging--pilot study. Radiology 2010, 255:622-628.
36. Crossen J.R., Garwood D., Glatstein E., et al. Neurobehavioral sequelae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 1994, 12:627-642.
37. Lai R., Abrey L.E., Rosenblum M.K., et al. Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study. Neurology 2004, 62:451-456.
38. Omuro A.M.P., DeAngelis L.M., Yahalom J., et al. Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up. Neurology 2005, 64:69-74.
39. De Ruiter M.B., Reneman L., Boogerd W., et al. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. Hum Brain Mapp 2012, 33:2971-2983.
40. Estève F., Rubin C., Grand S., et al. Transient metabolic changes observed with proton MR spectroscopy in normal human brain after radiation therapy. Int J Radiat Oncol Biol Phys 1998, 40:279-286.
41. Fernández-Bouzas A., Ramirez Jiménez H., Vázquez Zamudio J., et al. Brain calcifications and dementia in children treated with radiotherapy and intrathecal methotrexate. J Neurosurg Sci 1992, 36:211-214.
42. Lee K.F., Suh J.H. CT evidence of grey matter calcification secondary to radiation therapy. Comput Tomogr 1977, 1:103-110.
43. Chanson J.B., Anheim M., Lagha-Boukbiza O., et al. Severe generalized dystonia due to post radiotherapy cerebral calcifications. Rev Neurol (Paris) 2008, 164:477-480.
44. Ruben J.D., Dally M., Bailey M., et al. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys 2006, 65:499-508.
45. Sheline G.E., Wara W.M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys 1980, 6:1215-1228.
46. Malone S., Raaphorst G.P., Gray R., et al. Enhanced in vitro radiosensitivity of skin fibroblasts in two patients developing brain necrosis following AVM radiosurgery: a new risk factor with potential for a predictive assay. Int J Radiat Oncol Biol Phys 2000, 47:185-189.
47. Poisson M., Hauw J.J., Pouillart P., et al. Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy. Acta Neurochir (Wien) 1979, 51:27-42.
48. Schlienger M., Atlan D., Lefkopoulos D., et al. Linac radiosurgery for cerebral arteriovenous malformations: results in 169patients. Int J Radiat Oncol Biol Phys 2000, 46:1135-1142.
49. Tran T.A., Fuller G.N., Whitman G.J., et al. Radiologic - Pathologic conferences of the university of Texas M. D. Anderson Cancer Center delayed cerebral radiation necrosis. AJR Am J Roentgenol 2003, 180:70.
50. Dandois V., Rommel D., Renard L., et al. Substitution of 11C-methionine PET by perfusion MRI during the follow-up of treated high-grade gliomas: preliminary results in clinical practice. J Neuroradiol 2010, 37:89-97.
51. Chong V.F., Rumpel H., Fan Y.F., et al. Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 2001, 11:317-324.
52. Schlemmer H.P., Bachert P., Henze M., et al. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 2002, 44:216-222.
53. Weybright P., Sundgren P.C., Maly P., et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 2005, 185:1471-1476.
54. Barajas R.F., Chang J.S., Segal M.R., et al. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2009, 253:486-496.
55. Sugahara T., Korogi Y., Tomiguchi S., et al. Post therapeutic intra axial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from non-neoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000, 21:901-909.
56. Torcuator R., Zuniga R., Mohan Y.S., et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009, 94:63-68.
57. Gonzalez J., Kumar A.J., Conrad C.A., et al. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007, 67:323-326.
58. Levin V.A., Bidaut L., Hou P., et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 2011, 79:1487-1495.
59. Bitzer M., Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995, 26:131-136.
60. Patel D.A., Kochanski J., Suen A.W., et al. Clinical manifestations of non-coronary atherosclerotic vascular disease after moderate dose irradiation. Cancer 2006, 106:718-725.
61. Prefasi D., Martínez-Sánchez P., Fuentes B., et al. Bilateral carotid occlusion and progressive stenosis of vertebral arteries after radiotherapy in a young patient. Neurologia 2012, 27:122-124.
62. Li C.S., Schminke U., Tan T.Y. Extra cranial carotid artery disease in nasopharyngeal carcinoma patients with post-irradiation ischemic stroke. Clin Neurol Neurosurg 2010, 112:682-686.
63. Abayomi O.K. Neck irradiation, carotid injury and its consequences. Oral Oncol 2004, 40:872-878.
64. Cheng S.W.K., Ting A.C.W., Ho P., et al. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg 2004, 39:409-415.
65. Ullrich N.J., Robertson R., Kinnamon D.D., et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007, 68:932-938.
66. Fouladi M., Langston J., Mulhern R., et al. Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequelae of therapy. J Clin Oncol 2000, 18:824-831.
67. Hodel J., Rodallec M., Gerber S., et al. Susceptibility weighted magnetic resonance sequences "SWAN, SWI and VenoBOLD": technical aspects and clinical applications. J Neuroradiol 2012, 39:71-86.
68. Lupo J.M., Chuang C.F., Chang S.M., et al. 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys 2012, 82:493-500.
69. Jain R., Robertson P.L., Gandhi D., et al. Radiation-induced cavernomas of the brain. AJNR Am J Neuroradiol 2005, 26:1158-1162.
70. Heckl S., Aschoff A., Kunze S. Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer 2002, 94:3285-3291.
71. Poussaint T.Y., Siffert J., Barnes P.D., et al. Hemorrhagic vasculopathy after treatment of central nervous system neoplasia in childhood: diagnosis and follow-up. AJNR Am J Neuroradiol 1995, 16:693-699.
72. Nimjee S.M., Powers C.J., Bulsara K.R. Review of the literature on de novo formation of cavernous malformations of the central nervous system after radiation therapy. Neurosurg Focus 2006, 21:e4.
73. Vinchon M., Leblond P., Caron S., et al. Radiation-induced tumors in children irradiated for brain tumor: a longitudinal study. Childs Nerv Syst 2011, 27:445-453.
74. Duhem R., Vinchon M., Leblond P., et al. Cavernous malformations after cerebral irradiation during childhood: report of nine cases. Childs Nerv Syst 2005, 21:922-925.
75. Labauge P., Lefloch A., Chapon F., et al. Postirradiation spinal root cavernoma. Eur Neurol 2006, 56:256-257.
76. Motegi H., Kuroda S., Ishii N., et al. De novo formation of cavernoma after radiosurgery for adult cerebral arteriovenous malformation-case report. Neurol Med Chir (Tokyo) 2008, 48:397-400.
77. Battaglia F., Uro-Coste E., Delisle M.B., et al. Radiation-induced cavernoma: two cases. Rev Neurol (Paris) 2008, 164:468-471.
78. Larson J.J., Ball W.S., Bove K.E., et al. Formation of intracerebral cavernous malformations after radiation treatment for central nervous system neoplasia in children. J Neurosurg 1998, 88:51-56.
79. Amirjamshidi A., Abbassioun K. Radiation-induced tumors of the central nervous system occurring in childhood and adolescence. Four unusual lesions in three patients and a review of the literature. Childs Nerv Syst 2000, 16:390-397.
80. Ron E., Modan B., Boice J.D., et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988, 319:1033-1039.
81. Rubinstein A.B., Shalit M.N., Cohen M.L., et al. Radiation-induced cerebral meningioma: a recognizable entity. J Neurosurg 1984, 61:966-971.
82. Harrison M.J., Wolfe D.E., Lau T.S., et al. Radiation-induced meningiomas: experience at the Mount Sinai Hospital and review of the literature. J Neurosurg 1991, 75:564-574.
83. Al-Mefty O., Topsakal C., Pravdenkova S., et al. Radiation-induced meningiomas: clinical, pathological, cytokinetic, and cytogenetic characteristics. J Neurosurg 2004, 100:1002-1013.
84. Neglia J.P., Robison L.L., Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2006, 98:1528-1537.